SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-279529
Filing Date
2021-09-22
Accepted
2021-09-22 17:03:30
Documents
13
Period of Report
2021-09-20
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d193791d8k.htm   iXBRL 8-K 26185
2 EX-99.1 d193791dex991.htm EX-99.1 4176
  Complete submission text file 0001193125-21-279529.txt   150809

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA neog-20210920.xsd EX-101.SCH 2886
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20210920_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20210920_pre.xml EX-101.PRE 10949
6 EXTRACTED XBRL INSTANCE DOCUMENT d193791d8k_htm.xml XML 3368
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 211270195
SIC: 2835 In Vitro & In Vivo Diagnostic Substances